Counseling Veterans with Chronic Pain during the COVID-19 Pandemic: A Secondary Analysis of a Randomized Controlled Trial.

" : Funding sources: Research reported in this publication was made possible by Grant Number U24 AT009769 from the National Center for Complementary and Integrative Health (NCCIH) and the Office of Behavioral and Social Sciences Research (OBSSR) and cooperative agreement (UG3/UH3-AT009758) from the National Center for Complementary and Integrative Health and National Institute on Drug Abuse.: Disclosure: The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NCCIH, the OBSSR, and the National Institutes of Health. For more information about the Collaboratory, visit https://painmanagementcollaboratory.org.: Conflicts of interest: The authors report no conflict of interest."

" : Funding sources: Research reported in this publication was made possible by Grant Number U24 AT009769 from the National Center for Complementary and Integrative Health (NCCIH) and the Office of Behavioral and Social Sciences Research (OBSSR) and cooperative agreement (UG3/UH3-AT009758) from the National Center for Complementary and Integrative Health and National Institute on Drug Abuse.: Disclosure: The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the NCCIH, the OBSSR, and the National Institutes of Health. For more information about the Collaboratory, visit https://painmanagementcollaboratory.org.: Conflicts of interest: The authors report no conflict of interest."

"This ongoing two-arm, parallel-group, 36-week, multisite, controlled trial randomly assigns veterans applying for VA disability benefits across eight VA medical centers in New England to either the counseling intervention or usual care. Participating veterans must have served after 9/11; be seeking service connection for a back, neck, knee, or shoulder condition; report an average of four or more on the pain severity scale of the Brief Pain Inventory []; and not be receiving more than two pain treatment modalities at the VA. Assessments are collected at baseline and at 12 and 36 weeks. Main outcomes include pain severity and interference and use of nonpharmacological pain services. All study methods have been reviewed and approved by the VA Central Institutional Review Board and Yale University Human Investigation Committee and have been published on ClinicalTrials.gov (NCT04062214)."